CovidChloroV1, Main, Corpus, bibRecord, 000C50

Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?

Identifieur interne : 000C50 ( Main/Corpus ); précédent : 000C49; suivant : 000C51

Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?

Auteurs : François Mastroianni ; Vincent Colombie ; Geraldine Claes ; Axelle Gilles ; Frédéric Vandergheynst ; Sammy Place

Source :

European journal of case reports in internal medicine [ 2284-2594 ] ; 2020.

RBID : pubmed:32908842

Abstract

Hydroxychloroquine has been used worldwide as a first-line treatment for patients hospitalized with COVID-19. Little is known about COVID-19 and its effects on patients with congenital red blood cell disorders. We report a case of haemolytic anaemia in a 32-year-old patient and a fortuitous highlighting of G6PD deficiency. We reviewed the literature to assess the risk of hydroxychloroquine use in this context.

LEARNING POINTS

A rapid drop in haemoglobin in COVID-19 patients should alert physicians to test for haemolytic anaemia and enzymopathies.Our review of the literature shows that use of hydroxychloroquine is safe in G6PD-deficient patients.

DOI: 10.12890/2020_001875
PubMed: 32908842
PubMed Central: PMC7473690

Links to Exploration step

pubmed:32908842

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?</title>
<author><name sortKey="Mastroianni, Francois" sort="Mastroianni, Francois" uniqKey="Mastroianni F" first="François" last="Mastroianni">François Mastroianni</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, EpiCURA Hospital, Hornu, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Colombie, Vincent" sort="Colombie, Vincent" uniqKey="Colombie V" first="Vincent" last="Colombie">Vincent Colombie</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, EpiCURA Hospital, Hornu, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Claes, Geraldine" sort="Claes, Geraldine" uniqKey="Claes G" first="Geraldine" last="Claes">Geraldine Claes</name>
<affiliation><nlm:affiliation>Department of Haematology, EpiCURA Hospital, Hornu, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gilles, Axelle" sort="Gilles, Axelle" uniqKey="Gilles A" first="Axelle" last="Gilles">Axelle Gilles</name>
<affiliation><nlm:affiliation>Department of Haematology, EpiCURA Hospital, Hornu, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vandergheynst, Frederic" sort="Vandergheynst, Frederic" uniqKey="Vandergheynst F" first="Frédéric" last="Vandergheynst">Frédéric Vandergheynst</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Erasme Hospital, Brussels, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Place, Sammy" sort="Place, Sammy" uniqKey="Place S" first="Sammy" last="Place">Sammy Place</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, EpiCURA Hospital, Hornu, Belgium.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32908842</idno>
<idno type="pmid">32908842</idno>
<idno type="doi">10.12890/2020_001875</idno>
<idno type="pmc">PMC7473690</idno>
<idno type="wicri:Area/Main/Corpus">000C50</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000C50</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?</title>
<author><name sortKey="Mastroianni, Francois" sort="Mastroianni, Francois" uniqKey="Mastroianni F" first="François" last="Mastroianni">François Mastroianni</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, EpiCURA Hospital, Hornu, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Colombie, Vincent" sort="Colombie, Vincent" uniqKey="Colombie V" first="Vincent" last="Colombie">Vincent Colombie</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, EpiCURA Hospital, Hornu, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Claes, Geraldine" sort="Claes, Geraldine" uniqKey="Claes G" first="Geraldine" last="Claes">Geraldine Claes</name>
<affiliation><nlm:affiliation>Department of Haematology, EpiCURA Hospital, Hornu, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gilles, Axelle" sort="Gilles, Axelle" uniqKey="Gilles A" first="Axelle" last="Gilles">Axelle Gilles</name>
<affiliation><nlm:affiliation>Department of Haematology, EpiCURA Hospital, Hornu, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vandergheynst, Frederic" sort="Vandergheynst, Frederic" uniqKey="Vandergheynst F" first="Frédéric" last="Vandergheynst">Frédéric Vandergheynst</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Erasme Hospital, Brussels, Belgium.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Place, Sammy" sort="Place, Sammy" uniqKey="Place S" first="Sammy" last="Place">Sammy Place</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, EpiCURA Hospital, Hornu, Belgium.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">European journal of case reports in internal medicine</title>
<idno type="eISSN">2284-2594</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Hydroxychloroquine has been used worldwide as a first-line treatment for patients hospitalized with COVID-19. Little is known about COVID-19 and its effects on patients with congenital red blood cell disorders. We report a case of haemolytic anaemia in a 32-year-old patient and a fortuitous highlighting of G6PD deficiency. We reviewed the literature to assess the risk of hydroxychloroquine use in this context.</div>
<div type="abstract" xml:lang="en"><p><b>LEARNING POINTS</b>
</p>
<p>A rapid drop in haemoglobin in COVID-19 patients should alert physicians to test for haemolytic anaemia and enzymopathies.Our review of the literature shows that use of hydroxychloroquine is safe in G6PD-deficient patients.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32908842</PMID>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2284-2594</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>7</Volume>
<Issue>9</Issue>
<PubDate><Year>2020</Year>
</PubDate>
</JournalIssue>
<Title>European journal of case reports in internal medicine</Title>
<ISOAbbreviation>Eur J Case Rep Intern Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?</ArticleTitle>
<Pagination><MedlinePgn>001875</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.12890/2020_001875</ELocationID>
<Abstract><AbstractText>Hydroxychloroquine has been used worldwide as a first-line treatment for patients hospitalized with COVID-19. Little is known about COVID-19 and its effects on patients with congenital red blood cell disorders. We report a case of haemolytic anaemia in a 32-year-old patient and a fortuitous highlighting of G6PD deficiency. We reviewed the literature to assess the risk of hydroxychloroquine use in this context.</AbstractText>
<AbstractText Label="LEARNING POINTS" NlmCategory="UNASSIGNED">A rapid drop in haemoglobin in COVID-19 patients should alert physicians to test for haemolytic anaemia and enzymopathies.Our review of the literature shows that use of hydroxychloroquine is safe in G6PD-deficient patients.</AbstractText>
<CopyrightInformation>© EFIM 2020.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mastroianni</LastName>
<ForeName>François</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, EpiCURA Hospital, Hornu, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Colombie</LastName>
<ForeName>Vincent</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, EpiCURA Hospital, Hornu, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Claes</LastName>
<ForeName>Geraldine</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Department of Haematology, EpiCURA Hospital, Hornu, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gilles</LastName>
<ForeName>Axelle</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Haematology, EpiCURA Hospital, Hornu, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vandergheynst</LastName>
<ForeName>Frédéric</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Erasme Hospital, Brussels, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Place</LastName>
<ForeName>Sammy</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, EpiCURA Hospital, Hornu, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>08</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Italy</Country>
<MedlineTA>Eur J Case Rep Intern Med</MedlineTA>
<NlmUniqueID>101648453</NlmUniqueID>
<ISSNLinking>2284-2594</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">G6PD deficiency</Keyword>
<Keyword MajorTopicYN="N">Haemolytic anaemia</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
</KeywordList>
<CoiStatement>Conflicts of Interests: The Authors declare that there are no competing interests.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>06</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>07</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>9</Month>
<Day>10</Day>
<Hour>5</Hour>
<Minute>36</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>9</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32908842</ArticleId>
<ArticleId IdType="doi">10.12890/2020_001875</ArticleId>
<ArticleId IdType="pii">1875-1-15746-1-10-20200811</ArticleId>
<ArticleId IdType="pmc">PMC7473690</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Infect Dis (Lond). 2020 Sep;52(9):659-661</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32496938</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drug Saf. 2010 Sep 1;33(9):713-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20701405</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Haematol. 2020 Sep;105(3):357-359</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32324284</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2008 Jan 5;371(9606):64-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18177777</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2008 Sep;89(Pt 9):2080-2089</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18753216</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Care Res (Hoboken). 2018 Mar;70(3):481-485</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28556555</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Haematol. 2020 Jun 5;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32500556</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2008 Mar 15;197(6):812-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18269318</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C50 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000C50 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32908842
   |texte=   Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32908842" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?

Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki